Avadel Pharmaceuticals (AVDL)
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Artivion Inc (AORT)
Artivion Reports Second Quarter 2025 Financial Results
89bio Inc (ETNB)
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results
Fractyl Health Inc. (GUTS)
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
RxSight Inc. (RXST)
RxSight, Inc. Reports Second Quarter 2025 Financial Results
Athira Pharma Inc (ATHA)
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
Amphastar (AMPH)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
BioAtla Inc (BCAB)
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
Sight Sciences Inc (SGHT)
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
Lisata Therapeutics Inc (LSTA)
Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Ventyx Biosciences (VTYX)
Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Phio Pharmaceuticals Corp. (PHIO)
Ascendis Pharma (ASND)
Madrigal Pharmaceuticals Inc (MDGL)
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)